LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER research hub

AN INTERVENTIONAL PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER

This study looks at a new drug, PF-08634404, combined with chemotherapy for advanced lung cancer. It compares this combination to another treatment, pembrolizumab with chemotherapy, to see which works best and is safest for adults.